| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 372 |
| 1 | CARBOPLATIN | 241 |
| 2 | NIVOLUMAB | 202 |
| 3 | PANTOPRAZOLE | 132 |
| 4 | PACLITAXEL | 129 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 129 |
| 6 | PEMETREXED DISODIUM | 125 |
| 7 | FUROSEMIDE | 106 |
| 8 | SIMVASTATIN | 99 |
| 9 | RAMIPRIL | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN | 1 | 0.1250 |
| 1 | ALITRETINOIN | 5 | 0.0420 |
| 2 | METHACHOLINE CHLORIDE | 2 | 0.0286 |
| 3 | PEMIVIBART | 1 | 0.0233 |
| 4 | BEVACIZUMAB-ADCD | 4 | 0.0197 |
| 5 | 1169 HYDROGEN PEROXIDE SPRAY | 4 | 0.0129 |
| 6 | HYDROGEN PEROXIDE | 4 | 0.0121 |
| 7 | HALOBETASOL PROPIONATE AND TAZAROTENE | 2 | 0.0101 |
| 8 | MEGNESIUM OXIDE | 4 | 0.0096 |
| 9 | SODIUM HYPOCHLORITE | 2 | 0.0077 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 605 |
| 1 | Platinum-based Drug [EPC] | 279 |
| 2 | Corticosteroid [EPC] | 223 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 208 |
| 4 | Proton Pump Inhibitor [EPC] | 166 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 156 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 146 |
| 7 | Microtubule Inhibitor [EPC] | 141 |
| 8 | Loop Diuretic [EPC] | 131 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 108 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 605 | 0.0061 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 24 | 0.0041 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 10 | 0.0031 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 54 | 0.0025 |
| 4 | Antimalarial [EPC] | 21 | 0.0020 |
| 5 | Antiprotozoal [EPC] | 21 | 0.0020 |
| 6 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 7 | Antimycobacterial [EPC] | 40 | 0.0016 |
| 8 | Provitamin D2 Compound [EPC] | 48 | 0.0016 |
| 9 | Antiparasitic [EPC] | 7 | 0.0015 |